Cannabis, Probiotics and More: What Works Best for IBS? – Michigan Medicine
Cannabis, Probiotics and More: What Works Best for IBS? Michigan Medicine >View original article Contributor:
Month: October 2020
The greatest weight loss over four years came from eating these foods, study says
Last column, after dismissing nose plugs for weight loss, I promised an easy, tasty and lasting route to a healthy weight. The method I will describe is supported by considerable … Click to Continue » View original article Contributor:
Key COVID-19 Vaccine Review Committee Promises Science Is Guiding Their Process
As part of its routine review process, the U.S. Food and Drug Administration (FDA), the agency responsible for evaluating and deciding if the handful of COVID-19 vaccines currently being studied are safe and effective enough to use by people around the world, convened a committee on Oct. 22 to allow experts and the public to … Read more
Remdesivir Is the First FDA-Approved Treatment for COVID-19
On Oct. 22, the Food and Drug Administration (FDA) approved the first drug for treating COVID-19. Remdesivir, an antiviral medication given intravenously, is now approved for anyone hospitalized with COVID-19. It works by blocking the virus’s ability to make more copies of itself. Earlier this year, the drug had received emergency use authorization (EUA), which … Read more
You Can Now Get a COVID-19 Vaccine in China. That Might Not Be a Good Thing
Li Shurui didn’t hesitate. Faced with putting his life on hold indefinitely or the risk of catching COVID-19 by returning to university in the U.K., the 22-year-old business student decided to roll up his sleeve and receive an experimental coronavirus vaccine. Two injections of CoronaVac made by SinoVac (otherwise known as Beijing Kexing Bioproducts) cost … Read more
FDA advisory committee debates safety and efficacy standards for a coronavirus vaccine
The panel did not consider any specific vaccine, and the session served in large part as a venue for the agency to try to reassure the general public that any vaccine will be held to a high standard. View original article Contributor: Laurie McGinley
Moderna’s coronavirus vaccine trial is fully enrolled, 37 percent of participants are minorities
The company says it could have sufficient data to seek a regulatory OK in November. View original article Contributor: Carolyn Y. Johnson
D.C. already got $90 million back from FEMA for fighting covid-19. Its neighbors are far behind.
Some officials say there is plenty of time to seek reimbursements, but experts say they should act quickly. View original article Contributor: Rebecca Tan
FDA advisory committee debates safety and efficacy standards for a coronavirus vaccine
The panel did not consider any specific vaccine, and the session served in large part as a venue for the agency to try to reassure the general public that any vaccine will be held to a high standard. View original article Contributor: Laurie McGinley
Moderna’s coronavirus vaccine trial is fully enrolled, 37 percent of participants are minorities
The company says it could have sufficient data to seek a regulatory OK in November. View original article Contributor: Carolyn Y. Johnson